UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4695) 4695
Book Chapter (31) 31
Newsletter (31) 31
Magazine Article (25) 25
Conference Proceeding (8) 8
Newspaper Article (8) 8
Dissertation (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
science & technology (3384) 3384
life sciences & biomedicine (3164) 3164
humans (2988) 2988
male (2213) 2213
fructose - analogs & derivatives (2033) 2033
fructose - therapeutic use (1992) 1992
fructose (1607) 1607
female (1596) 1596
animals (1437) 1437
adult (1146) 1146
topiramate (1133) 1133
anticonvulsants - therapeutic use (1028) 1028
neurosciences & neurology (919) 919
fructose - adverse effects (884) 884
middle aged (835) 835
clinical neurology (800) 800
rats (718) 718
pharmacology & pharmacy (715) 715
treatment outcome (632) 632
fructose - administration & dosage (583) 583
adolescent (549) 549
glucose (503) 503
fructose - pharmacology (464) 464
anticonvulsants - adverse effects (447) 447
child (426) 426
psychiatry (424) 424
aged (423) 423
analysis (404) 404
insulin resistance (403) 403
neurosciences (392) 392
epilepsy - drug therapy (379) 379
diet (348) 348
dose-response relationship, drug (346) 346
epilepsy (339) 339
diabetes (336) 336
mice (334) 334
rats, wistar (322) 322
rodents (310) 310
metabolism (304) 304
drug therapy, combination (292) 292
obesity (290) 290
research (289) 289
biochemistry & molecular biology (286) 286
abridged index medicus (283) 283
neuroprotective agents - therapeutic use (272) 272
physiological aspects (270) 270
neurology (269) 269
double-blind method (267) 267
rats, sprague-dawley (264) 264
fructose - metabolism (262) 262
liver (258) 258
proteins (258) 258
disease models, animal (257) 257
drug therapy (254) 254
care and treatment (251) 251
oxidative stress (251) 251
insulin (248) 248
chemistry (246) 246
child, preschool (245) 245
enzymes (245) 245
health aspects (245) 245
dextrose (236) 236
time factors (232) 232
nutrition & dietetics (231) 231
medicine (222) 222
migraine (216) 216
research article (212) 212
anticonvulsants - administration & dosage (200) 200
liver - metabolism (199) 199
endocrinology & metabolism (197) 197
physical sciences (197) 197
risk factors (196) 196
anticonvulsants (194) 194
metabolic syndrome (194) 194
gene expression (193) 193
insulin - blood (193) 193
triazines - therapeutic use (192) 192
young adult (192) 192
blood glucose - metabolism (186) 186
inflammation (186) 186
medicine & public health (183) 183
migraine disorders - prevention & control (183) 183
anticonvulsants - pharmacology (181) 181
science & technology - other topics (177) 177
lipids (175) 175
studies (174) 174
multidisciplinary sciences (169) 169
valproic acid - therapeutic use (165) 165
antioxidants (164) 164
migraine disorders - drug therapy (163) 163
infant (162) 162
body weight (161) 161
diabetes mellitus (160) 160
retrospective studies (159) 159
liver - drug effects (158) 158
body weight - drug effects (154) 154
hypertension (152) 152
pediatrics (152) 152
physiology (152) 152
anti-obesity agents - therapeutic use (150) 150
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4369) 4369
German (170) 170
Spanish (79) 79
Russian (68) 68
Japanese (47) 47
French (45) 45
Italian (37) 37
Polish (18) 18
Portuguese (17) 17
Chinese (15) 15
Romanian (7) 7
Czech (6) 6
Hebrew (6) 6
Hungarian (6) 6
Dutch (5) 5
Swedish (5) 5
Finnish (2) 2
Slovak (2) 2
Danish (1) 1
Norwegian (1) 1
Serbian (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Epilepsia (Copenhagen), ISSN 0013-9580, 10/2017, Volume 58, Issue 10, pp. 1734 - 1741
Summary Objective Mesial temporal lobe epilepsy with hippocampal sclerosis (MTLE‐HS) is a common epilepsy syndrome that is often poorly controlled by... 
Drug response | Efficacy | Adverse drug reactions | Retention | Seizure freedom | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Pregabalin - therapeutic use | Triazines - therapeutic use | Humans | Middle Aged | Epilepsy, Temporal Lobe - drug therapy | Epilepsy, Temporal Lobe - physiopathology | Male | Sclerosis | Young Adult | Amines - therapeutic use | Vision Disorders - chemically induced | Adult | Female | Valproic Acid - therapeutic use | Retrospective Studies | gamma-Aminobutyric Acid - therapeutic use | Epilepsy, Temporal Lobe - pathology | Databases, Factual | Diplopia - chemically induced | Cyclohexanecarboxylic Acids - therapeutic use | Carbamazepine - analogs & derivatives | Vertigo - chemically induced | Dizziness - chemically induced | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Treatment Outcome | Hippocampus - pathology | Lethargy - chemically induced | Fructose - therapeutic use | Fructose - analogs & derivatives | Vigabatrin - therapeutic use | Adolescent | Aged | Ataxia - chemically induced | Benzodiazepines - therapeutic use | Medical research | Care and treatment | Anticonvulsants | Medicine, Experimental | Temporal lobe epilepsy | Seizures (Medicine) | Comparative analysis | Topiramate | Temporal lobe | Gabapentin | Epilepsy | Clinical trials | Valproic acid | Antiepileptic agents | Carbamazepine | Vertigo | Oxcarbazepine | Convulsions & seizures | Drowsiness | Ataxia | Hippocampus | Lamotrigine | Index Medicus
Journal Article
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 12/2017, Volume 2017, Issue 12, pp. CD011412 - CD011412
Background Epilepsy is a common neurological condition with a worldwide prevalence of around 1%. Approximately 60% to 70% of people with epilepsy will achieve... 
Triazines | Topiramate | Amines | Gabapentin | Epilepsy | Epilepsy: drugs for broad populations | Zonisamide | Oxcarbazepine | Child health | Isoxazoles | Antiepileptic drug monotherapy | Piracetam | Valproic Acid | Network Meta‐Analysis | gamma‐Aminobutyric Acid | Drugs for broad populations | Epilepsies, Partial | Remission Induction | Carbamazepine | Fructose | Antiepileptic drugs in broad populations with epilepsy | Neurology | Anticonvulsants | Phenobarbital | Cyclohexanecarboxylic Acids | Epilepsy, Generalized | Medicine General & Introductory Medical Sciences | Antiepileptic drugs | Phenytoin | Lamotrigine | Levetiracetam | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Triazines - therapeutic use | Epilepsies, Partial - drug therapy | Humans | Piracetam - therapeutic use | Amines - therapeutic use | Adult | Valproic Acid - therapeutic use | gamma-Aminobutyric Acid - therapeutic use | Network Meta-Analysis | Child | Cyclohexanecarboxylic Acids - therapeutic use | Carbamazepine - analogs & derivatives | Anticonvulsants - therapeutic use | Carbamazepine - therapeutic use | Fructose - therapeutic use | Fructose - analogs & derivatives | Phenobarbital - therapeutic use | Phenytoin - therapeutic use | Epilepsy, Generalized - drug therapy | Piracetam - analogs & derivatives | Epilepsy - drug therapy | Isoxazoles - therapeutic use | Index Medicus
Journal Article